.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2015 for a monstro...
.On the heels of a phase 3 succeed that neglected to blow away investors, Ironwood Pharmaceuticals i...
.Do not cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizi...
.Welcome to this week's Chutes & Ladders, our summary of considerable management hirings, firings...
.Commemorating his firm's upsized going public (IPO), Septerna chief executive officer Jeffrey Finer...
.AbbVie has actually returned to the source of its own antipsychotic giant Vraylar in search of anot...
.GenSight Biologics is full weeks far from lacking cash. Once again. The biotech just possesses adeq...
.Monopar Rehabs is recouping a drug coming from the dump of AstraZeneca's rare disease pipe. It has ...
.With new information out on Arcus Biosciences' speculative HIF-2a prevention, one group of experts ...
.After forming a genetics treatment collaboration with Dyno Rehabs in 2020, Roche is actually back f...